Published by Coherent Market Insights
Posted on September 20, 2021
4 min readLast updated: February 5, 2026
The home infusion therapy market, valued at $1.9B in 2020, is set to grow at a 6.5% CAGR, driven by chronic diseases and healthcare trends.
Coherent Market Insights released a new market study on 2021-2027 Home Infusion Therapy Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The research study provides estimates for 2021-2027 Home Infusion Therapy Market Forecast till 2027*.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/4276
Home infusion therapy services offer innovative healthcare services at the doorstep. Home therapy administers drug through the catheter or needle. It is used when the patient’s condition is very severe and cannot be cured with oral medication, as well as the infusion is needed multiple times in a day. Home infusion therapy involves the direct intravenous or subcutaneous injection of biologicals or medications into a patient at home.
The substances contained in home drugs include the usual medical ingredients such as antivirals, pain relievers, and digestive aid, however, other materials such as fats, sugar, and herbs are also used. Rheumatoid arthritis, multiple sclerosis, immune deficiencies, hemophilia, Crohn’s disease, congestive heart failure, gastrointestinal disorders, dehydration, and cancer and cancer-related pain are some of the diseases that need infusion therapies.
Market Dynamics:
Increasing incidence/prevalence of chronic diseases such as diabetes, cancer, and heart diseases is expected to propel the home infusion therapy market over the forecast period. Heart disease is the leading cause of death in the United States. According to the Centers for Disease Control and Prevention (CDC), a person dies of heart disease every 36 seconds in the United States.
Increasing geriatric population, increasing preference for home healthcare, and rising need to reduce hospital stay is expected to drive growth of the home infusion therapy market. For instance, in 2018, almost 36 million hospital admissions were registered in the United States, according to the American Hospital Association.
The emergence of COVID-19 is expected to offer substantial growth opportunities to players active in the prebiotics market. According to the World Health Organization, worldwide, as of 9:38am CET, 8 January 2021, there have been 86,436,449 confirmed cases of COVID-19, including 1,884,341 deaths.
Increasing adoption of inorganic growth strategies such as investments by key players are also expected to fuel the home infusion therapy market growth. For instance, in 2019, Nipro Corp. invested US$ 21 million in a medical devices company, JMI Syringes & Medical Devices Ltd., to expand its disposable syringe portfolio.
Home Infusion Therapy Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Becton, Dickinson and Company, B. Braun Melsungen AG, Nipro Corporation, ICU Medical, Inc., Baxter International Inc., Terumo Corporation, Smiths Medical, Fresenius Kabi AG, Eli Lilly and Company, JMS Co. Ltd., and NewIV Medical, Inc.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/4276
Reasons to Purchase this Report
• Current and future of global Home Infusion Therapy Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Major Point Answered in Home Infusion Therapy Market Research Study are:
Request Here Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/4276
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post home infusion therapy market is estimated to be valued at US$ 1,995.3 million in 2020 With CAGR of 6.5% appeared first on Gatorledger.
The article discusses the growth and dynamics of the home infusion therapy market.
Increasing chronic diseases, geriatric population, and preference for home healthcare drive growth.
Key players include Becton, Dickinson and Company, Nipro Corporation, and Baxter International Inc.
Explore more articles in the Research Reports category
